PICTON MAHONEY ASSET MANAGEMENT - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 43 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PICTON MAHONEY ASSET MANAGEMENT ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q2 2024$1
-80.0%
75,0000.0%0.00%
Q1 2024$5
+400.0%
75,0000.0%0.00%
Q4 2023$1
-80.0%
75,0000.0%0.00%
Q3 2023$50.0%75,0000.0%0.00%
Q2 2023$5
+66.7%
75,0000.0%0.00%
Q1 2023$3
-25.0%
75,0000.0%0.00%
Q4 2022$4
-99.9%
75,0000.0%0.00%
Q3 2022$5,000
-37.5%
75,0000.0%0.00%
Q2 2022$8,000
-52.9%
75,0000.0%0.00%
-100.0%
Q1 2022$17,00075,0000.00%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q4 2023
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 163,538$1,679,5840.10%
Radcliffe Capital Management, L.P. 150,000$1,540,5450.05%
Telemetry Investments, L.L.C. 125,114$50.01%
Q Global Advisors, LLC 170,785$70.00%
Atalaya Capital Management LP 225,000$9,0000.00%
DIFESA CAPITAL MANAGEMENT, LP 62,500$2,4560.00%
Segantii Capital Management Ltd 5,000$51,0000.00%
PERISCOPE CAPITAL INC. 957,098$40,6000.00%
MMCAP International Inc. SPC 375,000$16,1620.00%
Sage Rock Capital Management LP 91,999$3,9650.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders